- Home
- BNR vs DRIO Comparison
BNR vs DRIO Comparison
Compare BNR & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- DRIO
- Stock Information
- Founded
- BNR 2014
- DRIO 2011
- Country
- BNR China
- DRIO United States
- Employees
- BNR N/A
- DRIO N/A
- Industry
- BNR Medical Specialities
- DRIO Medical/Dental Instruments
- Sector
- BNR Health Care
- DRIO Health Care
- Exchange
- BNR Nasdaq
- DRIO Nasdaq
- Market Cap
- BNR 38.3M
- DRIO 30.5M
- IPO Year
- BNR 2020
- DRIO N/A
- Fundamental
- Price
- BNR $6.47
- DRIO $0.58
- Analyst Decision
- BNR
- DRIO Strong Buy
- Analyst Count
- BNR 0
- DRIO 2
- Target Price
- BNR N/A
- DRIO $2.50
- AVG Volume (30 Days)
- BNR 53.8K
- DRIO 175.1K
- Earning Date
- BNR 08-21-2025
- DRIO 08-11-2025
- Dividend Yield
- BNR N/A
- DRIO N/A
- EPS Growth
- BNR N/A
- DRIO N/A
- EPS
- BNR N/A
- DRIO N/A
- Revenue
- BNR $72,112,038.00
- DRIO $28,034,000.00
- Revenue This Year
- BNR $136.32
- DRIO $20.85
- Revenue Next Year
- BNR N/A
- DRIO $17.09
- P/E Ratio
- BNR N/A
- DRIO N/A
- Revenue Growth
- BNR 0.53
- DRIO 47.20
- 52 Week Low
- BNR $2.18
- DRIO $0.50
- 52 Week High
- BNR $9.48
- DRIO $1.55
- Technical
- Relative Strength Index (RSI)
- BNR 60.79
- DRIO 31.86
- Support Level
- BNR $5.81
- DRIO $0.52
- Resistance Level
- BNR $9.48
- DRIO $0.74
- Average True Range (ATR)
- BNR 0.90
- DRIO 0.05
- MACD
- BNR 0.12
- DRIO -0.02
- Stochastic Oscillator
- BNR 45.86
- DRIO 26.48
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.